Items of Interest

Rollins, Judy A.
May 2007
Pediatric Nursing;May/Jun2007, Vol. 33 Issue 3, p279
Academic Journal
The article investigates the vaccines which offer preventive measures on various viral and bacterial infection among children in the U.S. The study evaluates the immune response and safety profile of various vaccines including diphtheria, tetanus, acellular pertussis-inactivated poliovirus (DTaP-IPV), Haemophilus influenzae type b (Hib) and Haemophilus influenza type b Conjugate Vaccine Tetanus Toxoid Conjugate (Hib-MenCY-TT).


Related Articles

  • Incidence of Pneumococcal Disease Due to Non-Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998-2004. Hicks, Lauri A.; Harrison, Lee H.; Flannery, Brendan; Hadler, James L.; Schaffner, William; Craig, Allen S.; Jackson, Delois; Thomas, Ann; Beall, Bernard; Lynfield, Ruth; Reingold, Arthur; Farley, Monica M.; Whitney, Cynthia G. // Journal of Infectious Diseases;11/1/2007, Vol. 196 Issue 9, p1346 

    Background. Widespread use of pneumococcal conjugate vaccine (PCV7) resulted in decreases in invasive disease among children and elderly persons. The benefits may be offset by increases in disease due to serotypes not included in the vaccine (hereafter, ‘nonvaccine serotypes’). We...

  • Chapter 13: Prospects for a streptococcal vaccine.  // Rheumatic Fever & Rheumatic Heart Disease;1/1/2004, p106 

    Chapter 13 of the book "Rheumatic Fever and Rheumatic Heart Disease" is presented. It discusses the history of attempts in preventing group A streptococcal infection through immunization especially during the twentieth century in North Africa. It also highlights M-protein-based as the most...

  • GOVERNMENT TO STOCKPILE ANTHRAX VACCINE, PAPER SAYS. Kaye, Donald // Clinical Infectious Diseases;5/1/2004, Vol. 38 Issue 9, p4 

    According the newspaper "The Washington Post," the U.S. government has decided to order an additional 75 million doses of an experimental anthrax vaccine, enough to inoculate 25 million people in case of a biological attack. "The Washington Post," said the government would order 75 million doses...

  • Regulating the adaptive immune response to respiratory virus infection. Braciale, Thomas J.; Sun, Jie; Kim, Taeg S. // Nature Reviews Immunology;Apr2012, Vol. 12 Issue 4, p295 

    Recent years have seen several advances in our understanding of immunity to virus infection of the lower respiratory tract, including to influenza virus infection. Here, we review the cellular targets of viruses and the features of the host immune response that are unique to the lungs. We...

  • Immunology: Virus and bacterium gang up on host. van Ooij, Christiaan // Nature Reviews Microbiology;Aug2011, Vol. 9 Issue 8, p559 

    The article discusses a paper by Gabriel Núñez and colleagues which describes an immunological process by which viral infections heighten immune response to bacterial infection. It references the article "Viral infection augments Nod1/2 signaling to potentiate lethality associated with...

  • Limiting inflammatory responses during activation of innate immunity. Jiahuai Han; Ulevitch, Richard J. // Nature Immunology;Dec2005, Vol. 6 Issue 12, p1198 

    The idea of the importance of mounting an inflammatory response for effective immunity is supported by a multiplicity of experimental data. It is also well understood that resolution of inflammation is essential for maintaining the balance between health and disease. When the normal regulatory...

  • Peripheral Blood Lymphocyte Subsets in Acute Human Melioidosis. Ramsay, S. C.; Ketheesan, N.; Norton, R.; Watson, A.-M.; LaBrooy, J. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2002, Vol. 21 Issue 7, p566 

    This article discusses the pathology of acute human melioidosis. Melioidosis is a gram-negative bacterial infection caused by Burkholderia pseudomallei. Although it often occurs in individuals with coexistent disease predisposing to immunosuppression, it also occurs in apparently normal...

  • Pneumococcal Serotype-Specific Antibodies Persist through Early Childhood after Infant Immunization: Follow-Up from a Randomized Controlled Trial. Trück, Johannes; Snape, Matthew D.; Tatangeli, Florencia; Voysey, Merryn; Yu, Ly-Mee; Faust, Saul N.; Heath, Paul T.; Finn, Adam; Pollard, Andrew J. // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Background: In a previous UK multi-center randomized study 278 children received three doses of 7-valent (PCV-7) or 13-valent (PCV-13) pneumococcal conjugate vaccine at 2, 4 and 12 months of age. At 13 months of age, most of these children had pneumococcal serotype-specific IgG concentrations...

  • Transcriptome Analysis Reveals Comprehensive Insights into the Early Immune Response of Large Yellow Croaker (Larimichthys crocea) Induced by Trivalent Bacterial Vaccine. Zhang, Xin; Mu, Yinnan; Mu, Pengfei; Ao, Jingqun; Chen, Xinhua // PLoS ONE;1/30/2017, Vol. 12 Issue 1, p1 

    Vaccination is an effective and safe strategy for combating bacterial diseases in fish, but the mechanisms underlying the early immune response after vaccination remain to be elucidated. In the present study, we used RNA-seq technology to perform transcriptome analysis of spleens from large...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics